Details for New Drug Application (NDA): 077273
✉ Email this page to a colleague
NDA 077273 describes TUSSICAPS, which is a drug marketed by Ecr Pharma and is included in one NDA. Additional details are available on the TUSSICAPS profile page.
The generic ingredient in TUSSICAPS is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
The generic ingredient in TUSSICAPS is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
Summary for 077273
| Tradename: | TUSSICAPS |
| Applicant: | Ecr Pharma |
| Ingredient: | chlorpheniramine polistirex; hydrocodone polistirex |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 8MG MALEATE;EQ 10MG BITARTRATE | ||||
| Approval Date: | Sep 24, 2007 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 4MG MALEATE;EQ 5MG BITARTRATE | ||||
| Approval Date: | Sep 24, 2007 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
